French Rapid Testing Company Scoops Up Chembio Diagnostics For $17M

By: via Benzinga
Privately heldBiosynex SAhasagreed to acquireChembio Diagnostics Inc(NASDAQ: CEMI) for $0.45 per share ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.